Executive and visuospatial deficits in patients with chronic progressive external ophthalmoplegia and Kearns-Sayre Syndrome

Brain

Volumn 126, Issue 5, 2003, Pages 1231-1240

  Bosbach, Simone ^a   Kornblum, Comelia ^a   Schröder, Rolf ^a   Wagner, Michael ^a,b  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

Chronic progressive external ophthalmoplegia; Executive functions; Kearns Sayre syndrome; Mitochondrial disorders; Neuropsychological deficits

Indexed keywords

LEUCINE TRANSFER RNA; MITOCHONDRIAL DNA;

ADULT; ARTICLE; CLINICAL ARTICLE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DEPTH PERCEPTION; EXTERNAL OPHTHALMOPLEGIA; FEMALE; GENE DELETION; GENETIC ANALYSIS; HUMAN; INTELLECTUAL IMPAIRMENT; KEARNS SAYRE SYNDROME; MALE; MOLECULAR GENETICS; NEUROPSYCHOLOGICAL TEST; OCCIPITAL LOBE; PARIETAL LOBE; POINT MUTATION; PREFRONTAL CORTEX; PRIORITY JOURNAL; QUALITY OF LIFE; SKELETAL MUSCLE; VERBAL COMMUNICATION;

ADULT; AGED; ANALYSIS OF VARIANCE; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; DNA, MITOCHONDRIAL; FEMALE; GENE DELETION; HUMANS; KEARNS-SAYER SYNDROME; LANGUAGE TESTS; MALE; MEMORY; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; OPHTHALMOPLEGIA, CHRONIC PROGRESSIVE EXTERNAL; POINT MUTATION; QUALITY OF LIFE;

EID: 0242584408     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/awg101     Document Type: Article

References (43)

1. Amemiya S, Hamamoto M, Goto Y, Komaki H, Nishino I, Nonaka I, et al. Psychosis and progressive dementia: presenting features of a mitochondriopathy. Neurology 2000; 55: 600-1.
2. Anderson SW, Damasio H, Jones RD, Tranel D. Wisconsin Card Sorting Test performance as a measure of frontal lobe damage. J Clin Exp Neuropsychol 1991; 13: 909-22.
3. Barbiroli B, Montagna P, Martinelli P, Lodi R, Iotti S, Cortelli P, et al. Defective brain energy metabolism shown by in vivo 31P MR spectroscopy in 28 patients with mitochondrial cytopathies. J Cereb Blood Flow Metab 1993; 13: 469-74.
4. Berkovic SF, Carpenter SE, Evans A, Karpati G, Shoubridge EA, Andermann F, et al. Myoclonus epilepsy and ragged-red fibres (MERRF). Brain 1989; 112: 1231-60.
5. Binder LM. Constructional strategies on complex figure drawings after unilateral brain damage. J Clin Neuropsychol 1982; 4: 51-8.
6. Brickenkamp P. D2-Aufmerksamkeits-Belastungs-Test. Handanweisung. Göttingen: Hogrefe; 1981.
7. Bullinger M, Kirchberger I. SF-36 Fragebogen zum Gesundheitszustand. Handanweisung. Göttingen: Hogrefe; 1998.
8. Chu BC, Terae S, Takahashi C, Kikuchi Y, Miyasaka K, Abe S, et al. MRI of the brain in the Kearns-Sayre syndrome: report of four cases and a review. Neuroradiology 1999; 41: 759-64.
9. DeRenzi E, Vignolo L. The Token Test: a sensitive test to detect receptive disturbances in aphasics. Brain 1962; 85: 665-78.
10. DeVolder A, Ghilain S, de Barsy T, Goffinet AM. Brain metabolism in mitochondrial encephalomyopathy: a PET study. J Comput Assist Tomogr 1988; 12: 854-7.
11. DiMauro S, Moraes CT. Mitochondrial encephalomyopathies. Arch Neurol 1993; 50: 1197-208.
12. Eleff SM, Barker PB, Blackband SJ, Chatham JC, Lutz NW, Johns DR, et al. Phosphorus magnetic resonance spectroscopy of patients with mitochondrial cytopathies demonstrates decreased levels of brain phosphocreatine. Ann Neurol 1990; 27: 626-30.
13. Frackowiak RS, Herold S, Petty RK, Morgan-Hughes JA. The cerebral metabolism of glucose and oxygen measured with positron tomography in patients with mitochondrial diseases. Brain 1988; 111: 1009-24.
14. Heaton RK, Chelune GJ, Talley JL, Kay GG, Curtis G. Wisconsin Card Sorting Test (WCST). Odessa (FL): Psychological Assessment Resources; 1991.
15. Helmstaedter C, Durwen HF. The Verbal Learning and Retention Test. A useful and differentiated tool in evaluating verbal memory performance. [German]. Schweiz Arch Neurol Psychiatr 1990; 141: 21-30.
16. Holt IJ, Harding AE, Cooper JM, Schapira AH, Toscano A, Clark JB, et al. Mitochondrial myopathies: clinical and biochemical features of 30 patients with major deletions of muscle mitochondrial DNA. Ann Neurol 1989; 26: 699-708.
17. Howell N. Human mitochondrial diseases: answering questions and questioning answers. Int Rev Cytol 1999; 186: 49-116.
18. Kartsounis LD, Troung DD, Morgan-Hughes JA, Harding AE. The neuropsychological features of mitochondrial myopathies and encephalomyopathies. Arch Neurol 1992; 49: 158-60.
19. Kathmann N, Wagner M, Satzger W, Engel RR. Vigilanzmessung auf Verhaltensebene: Der Continuous Performance Test Muenchen (CPT-M). In: Moeller HJ, Engel RR, Hoff P, editors. Befunderhebung in der Psychiatrie: Lebensqualitaet, Negativsymptomatik und andere aktuelle Entwicklungen. Wien: Springer; 1996. p. 331-8.
20. Lang CJ, Brenner P, Heuß D, Engelhardt A, Reichmann H, Seibel P, et al. Neuropsychological status of mitochondrial encephalomyopathies. Eur J Neurol 1995; 2: 171-6.
21. Madsen PL, Linde R, Hasselbalch SG, Paulson OB, Lassen NA. Activation-induced resetting of cerebral oxygen and glucose uptake in the rat. J Cereb Blood Flow Metab 1998; 18: 742-8.
22. Matthews PM, Berkovic SF, Shoubridge EA, Andermann F, Karpati G, Carpenter S, et al. In-vivo magnetic resonance spectroscopy of brain and muscle in a type of mitochondrial encephalomyopathy (MERRF). Ann Neurol 1991; 29: 435-8.
23. Molnar MJ, Valikovics A, Molnar S, Tron L, Dioszeghy P, Mechler F, et al. Cerebral blood flow and glucose metabolism in mitochondrial disorders. Neurology 2000; 55: 544-8.
24. Morgan-Hughes JA. Mitochondrial diseases. In: Engel AG, Franzini-Armstrong C, editors. Myology. 2nd ed. New York: McGraw-Hill; 1994. p. 1610-60.
25. Oswald W, Roth E. Der Zahlenverbindungstest. Göttingen: Hogrefe; 1987.
26. Rango M, Bozalli M, Prelle A, Scarlato G, Bresolin N. Brain activation in normal subjects and in patients affected by mitochondrial disease without clinical central nervous system involvement: a phosphorus magnetic resonance spectroscopy study. J Cereb Blood Flow Metab 2001; 21: 85-91.
27. Recanzone GH, Schreiner CE, Merzenich MM. Plasticity in the frequency representation of primary auditory cortex following discrimination training in adult owl monkeys. J Neurosci 1993; 13: 87-103.
28. Reichmann H. Neurogenetik. Akt Neurol 1996; 23: 45-53.
29. Roland PE, Friberg L. Localization of cortical areas activated by thinking. J Neurophysiol 1985; 53: 1219-43.
30. Roland PE, Eriksson L, Stone-Elander S, Widen L. Does mental activity change the oxidative metabolism of the brain? J Neurosci 1987; 7: 2373-89.
31. Sartor H, Loose R, Tucha O, Klein HE, Lange KW. MELAS: a neuropsychological and radiological follow-up study. Acta Neurol Scand 2002; 106: 309-13.
32. Schmidt KH, Metzler P. Wortschatztest (WST). Weinheim: Beltz; 1992.
33. Schroeder R, Vielhaber S, Wiedemann FR, Kornblum C, Papassotiropoulos A, Broich P, et al. New insights into the metabolic consequences of large-scale mtDNA deletions: a quantitative analysis of biochemical, morphological, and genetic findings in human skeletal muscle. J Neuropathol Exp Neurol 2000; 59: 353-60.
34. Shanske S, Moraes CT, Lombes A, Miranda AF, Bonilla E, Lewis P, et al. Widespread tissue distribution of mitochondrial DNA deletions in Kearns-Sayre syndrome. Neurology 1990; 40: 24-8.
35. Shepherd M, Findlay JM, Hockey RJ. The relationship between eye movements and spatial attention. Q J Exp Psychol A 1986; 38: 475-91.
36. Sparaco M, Bonilla E, DiMauro S, Powers JM. Neuropathology of mitochondrial encephalomyopathies due to mitochondrial DNA defects. J Neuropathol Exp Neurol 1993; 52: 1-10.
37. Spreen O, Strauss E. A compendium of neuropsychological tests. Administration, norms, and commentary. 2nd ed. New York (NY): Oxford University Press; 1998.
38. Sue CM, Crimmins DS, Soo YS, Pamphlett R, Presgrave CM, Kotsimbos N, et al. Neuroradiological features of six kindreds with MELAS tRNA(Leu) A3243G point mutation: implications for pathogenesis. J Neurol Neurosurg Psychiatry 1998; 65: 233-40.
39. Taylor LB. Scoring criteria for the Rey-Osterrieth Complex Figure Test. In: Spreen O, Strauss E, editors. A compendium of neuropsychological tests. Administration, norms, and commentary. New York (NY): Oxford University Press; 1998. p. 350-1.
40. Turconi AC, Benti R, Castelli E, Pochintesta S, Felisari G, Comi G, et al. Focal cognitive impairment in mitochondrial encephalomyopathies: a neuropsychological and neuroimaging study. J Neurol Sci 1999; 170: 57-63.
41. Valanne L, Ketonen L, Majander A, Suomalainen A, Pihko H. Neuroradiologic findings in children with mitochondrial disorders. AJNR Am J Neuroradiol 1998; 19: 369-77.
42. Warrington EK, James M. The visual object and shape perception battery. Bury St Edmunds: Thames Valley Test Company; 1991.
43. White M, Lalonde R, Botez-Marquard T. Neuropsychologic and neuropsychiatric characteristics of patients with Friedreich's ataxia. Acta Neurol Scand 2000; 102: 222-6.